IL100646A - N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept[b] indoles their preparation and pharmaceutical compositions containing them - Google Patents

N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept[b] indoles their preparation and pharmaceutical compositions containing them

Info

Publication number
IL100646A
IL100646A IL10064692A IL10064692A IL100646A IL 100646 A IL100646 A IL 100646A IL 10064692 A IL10064692 A IL 10064692A IL 10064692 A IL10064692 A IL 10064692A IL 100646 A IL100646 A IL 100646A
Authority
IL
Israel
Prior art keywords
imidazol
compound
phenyl
formula
methyl
Prior art date
Application number
IL10064692A
Other languages
English (en)
Other versions
IL100646A0 (en
Inventor
Paolo Cozzi
Antonio Pillan
Maurizio Pulici
Patricia Salvati
Angelo Daniele Volpi
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IL100646A0 publication Critical patent/IL100646A0/xx
Publication of IL100646A publication Critical patent/IL100646A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL10064692A 1991-01-22 1992-01-14 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept[b] indoles their preparation and pharmaceutical compositions containing them IL100646A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919101375A GB9101375D0 (en) 1991-01-22 1991-01-22 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole

Publications (2)

Publication Number Publication Date
IL100646A0 IL100646A0 (en) 1992-09-06
IL100646A true IL100646A (en) 1995-11-27

Family

ID=10688812

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10064692A IL100646A (en) 1991-01-22 1992-01-14 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept[b] indoles their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US5238953A (fr)
EP (1) EP0496237B1 (fr)
JP (1) JPH04321683A (fr)
KR (1) KR920014806A (fr)
AT (1) ATE134191T1 (fr)
AU (1) AU641837B2 (fr)
CA (1) CA2059741A1 (fr)
DE (1) DE69208271D1 (fr)
FI (1) FI920247A7 (fr)
GB (1) GB9101375D0 (fr)
HU (1) HUT60492A (fr)
IE (1) IE920173A1 (fr)
IL (1) IL100646A (fr)
MX (1) MX9200178A (fr)
MY (1) MY106807A (fr)
NZ (1) NZ241317A (fr)
TW (1) TW203610B (fr)
ZA (1) ZA92428B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103130T3 (es) * 1993-06-14 1997-08-16 Pfizer Inhibidores imidazoles como la lipoxigenasa.
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
US6177440B1 (en) 1996-10-30 2001-01-23 Eli Lilly And Company Substituted tricyclics
US6713645B1 (en) * 1996-10-30 2004-03-30 Eli Lilly And Company Substituted tricyclics
US6410583B1 (en) 2000-07-25 2002-06-25 Merck Frosst Canada & Co. Cyclopentanoindoles, compositions containing such compounds and methods of treatment
AR038136A1 (es) 2002-01-24 2004-12-29 Merck Frosst Canada Inc Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE486478A (fr) * 1947-12-24
GB1418703A (en) * 1973-06-02 1975-12-24 Pfizer Ltd 3-alkyl-9-substituted-1,2,3,4-tetrahydrocarbazoles
CA1046519A (fr) * 1975-08-28 1979-01-16 American Home Products Corporation Derives tricycliques de l'acide acetique et de l'indole
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4436746A (en) * 1982-09-30 1984-03-13 Ciba-Geigy Corporation Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
EP0234708B1 (fr) * 1986-01-23 1991-02-27 Merck Frosst Canada Inc. Acides tétrahydrocarbazole 1-alcanoiques
US4808608A (en) * 1986-01-23 1989-02-28 Merck & Co., Inc. Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
CA1326030C (fr) * 1987-07-21 1994-01-11 John W. Gillard Acides cyclohept[b]indole alcanoiques
DK185489A (da) * 1988-04-22 1989-10-23 Duphar Int Res Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
US5221678A (en) * 1990-07-26 1993-06-22 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
US5187180A (en) * 1990-07-26 1993-02-16 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes

Also Published As

Publication number Publication date
AU641837B2 (en) 1993-09-30
JPH04321683A (ja) 1992-11-11
KR920014806A (ko) 1992-08-25
CA2059741A1 (fr) 1992-07-23
EP0496237A3 (en) 1992-12-09
IL100646A0 (en) 1992-09-06
IE920173A1 (en) 1992-07-29
EP0496237A2 (fr) 1992-07-29
EP0496237B1 (fr) 1996-02-14
ZA92428B (en) 1992-10-28
NZ241317A (en) 1993-08-26
GB9101375D0 (en) 1991-03-06
HU9200190D0 (en) 1992-04-28
FI920247A7 (fi) 1992-07-23
TW203610B (fr) 1993-04-11
FI920247A0 (fi) 1992-01-20
ATE134191T1 (de) 1996-02-15
MX9200178A (es) 1992-07-01
DE69208271D1 (de) 1996-03-28
MY106807A (en) 1995-07-31
AU1020792A (en) 1992-07-30
US5238953A (en) 1993-08-24
HUT60492A (en) 1992-09-28

Similar Documents

Publication Publication Date Title
US4643998A (en) Imidazolylalkylthienyl tetrahydropyridazines and processes for their use
US5246957A (en) N-imidazolyl derivatives of substituted indole
EP0630374A1 (fr) Derives d'imidazole, de triazole et de tetrazole
JPH0454662B2 (fr)
US5554629A (en) 4-substituted 1,2,4-triazole derivatives
US5204364A (en) N-imidazolyl- and n-imidazolylmethyl-derivatives of substituted bicyclic compounds
US4568687A (en) N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
IE54473B1 (en) Imidazolylphenyl-tetrahydropyridazines, processes for their preparation and pharmaceutical preparations containing them
EP0496237B1 (fr) Dérivés N-imidazolyliques de tétrahydrocarbazole et cyclohept[b]-indole substitués
US5283254A (en) 2-(imidazol-1-yl)-2-benzylethyldiene-aminoxyalkanoic acid derivatives
AU644632B2 (en) Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives
RU2083566C1 (ru) N-имидазолильные производные замещенных алкоксииминотетрагидронафталинов или хроманов или их фармацевтически приемлемые соли и фармацевтическая композиция, проявляющая активность антагониста тромбоксана и ингибитора тромбоксансинтазы
EP0293500A1 (fr) 3-Hétéroalkyl-2,4-quinazoline-diones, 3-hétéroaryl-1,2,3-benzotriazin-4(3H)-ones, 3-hétéroarylalkyl-4-quinazolinone
JPH11510177A (ja) 置換1−インドリルプロピル−4−フェネチルピペラジン誘導体
JPS6016975A (ja) 双環性化合物のn−イミダゾリル誘導体およびそれらの製造法
WO1995021167A1 (fr) Derives de triazole

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void